One University of Kentucky researcher is working to develop new techniques for radiation treatment to improve survival rates of patients with a specific type of cancer.
Ka-wing Fong, Ph.D., and Eric Rellinger, M.D., were named V Scholars by the V Foundation for Cancer Research and will each receive $600,000 to fund their individual cancer research projects.
One of the University of Kentucky Markey Cancer Center’s leading researchers has been selected to participate in the inaugural cohort of the National Institutes of Health (NIH) funded Institutional Development Award (IDeA) Regional Entrepreneurship Development (I-RED) Program.
The University of Kentucky will be home to a new research center focused on tobacco regulations in the Commonwealth named the Appalachian Tobacco Regulatory Science Team (AppalTRuST).
The University of Kentucky Markey Cancer Center announced today that it has earned a National Cancer Institute “Comprehensive” Cancer Center designation, the highest level of recognition awarded by the NCI.
While cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentucky and Appalachian Kentucky, according to a new University of Kentucky Markey Cancer Center study.
Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.
